Organo Corp.

  • Market Cap: Mid Cap
  • Industry: Industrial Manufacturing
  • ISIN: JP3201600008
JPY
15,390.00
7690 (99.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Strong Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 17.33%

  • Healthy long term growth as Net Sales has grown by an annual rate of 11.09% and Operating profit at 25.92%
  • Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 96.69
2

Positive results in Jun 25

3

With ROCE of 24.55%, it has a very attractive valuation with a 2.82 Enterprise value to Capital Employed

4

Company is among the highest 1% of companies rated by MarketsMojo across all 4,000 stocks

 
5

Consistent Returns over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

JPY 539,163 Million (Mid Cap)

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.06

stock-summary
Return on Equity

21.06%

stock-summary
Price to Book

4.52

Revenue and Profits:
Net Sales:
38,110 Million
(Quarterly Results - Jun 2025)
Net Profit:
3,642 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
138.24%
0%
138.24%
6 Months
84.98%
0%
84.98%
1 Year
85.42%
0%
85.42%
2 Years
297.67%
0%
297.67%
3 Years
512.54%
0%
512.54%
4 Years
891.3%
0%
891.3%
5 Years
946.94%
0%
946.94%

Organo Corp. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
11.09%
EBIT Growth (5y)
25.92%
EBIT to Interest (avg)
96.69
Debt to EBITDA (avg)
0.46
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
1.12
Tax Ratio
25.25%
Dividend Payout Ratio
30.45%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.33%
ROE (avg)
14.66%

Valuation key factors

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.91
EV to EBIT
11.48
EV to EBITDA
10.81
EV to Capital Employed
2.82
EV to Sales
2.19
PEG Ratio
0.37
Dividend Yield
0.01%
ROCE (Latest)
24.55%
ROE (Latest)
20.00%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 20.53% vs 6.78% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 35.74% vs 67.69% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "38,110.00",
          "val2": "31,619.00",
          "chgp": "20.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "7,405.00",
          "val2": "4,428.00",
          "chgp": "67.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "65.00",
          "val2": "65.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,642.00",
          "val2": "2,683.00",
          "chgp": "35.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "182.50%",
          "val2": "126.60%",
          "chgp": "5.59%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 8.59% vs 13.54% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 39.53% vs 47.35% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "163,269.00",
          "val2": "150,356.00",
          "chgp": "8.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "33,046.00",
          "val2": "24,555.00",
          "chgp": "34.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "246.00",
          "val2": "240.00",
          "chgp": "2.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "24,186.00",
          "val2": "17,334.00",
          "chgp": "39.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "190.60%",
          "val2": "149.90%",
          "chgp": "4.07%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary

Jun'25
Jun'24
Change(%)
Net Sales
38,110.00
31,619.00
20.53%
Operating Profit (PBDIT) excl Other Income
7,405.00
4,428.00
67.23%
Interest
65.00
65.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
3,642.00
2,683.00
35.74%
Operating Profit Margin (Excl OI)
182.50%
126.60%
5.59%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 20.53% vs 6.78% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 35.74% vs 67.69% in Jun 2024

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
163,269.00
150,356.00
8.59%
Operating Profit (PBDIT) excl Other Income
33,046.00
24,555.00
34.58%
Interest
246.00
240.00
2.50%
Exceptional Items
0.00
0.00
Consolidate Net Profit
24,186.00
17,334.00
39.53%
Operating Profit Margin (Excl OI)
190.60%
149.90%
4.07%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 8.59% vs 13.54% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 39.53% vs 47.35% in Mar 2024

stock-summaryCompany CV
About Organo Corp. stock-summary
stock-summary
Organo Corp.
Industrial Manufacturing
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available